Back to top

Tale of the Tape

Zacks Equity Research

Can Novavax (NVAX) Continue to Rise?
January 20, 2014


Trades from $3
Novavax, Inc. (NVAX) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because NVAX is now in overbought territory with an RSI value of 80.4. Furthermore,  Novavax currently has a Zacks Rank #4 (Sell), suggesting that investors may want to consider exiting this stock now before it falls back to Earth.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novavax, Inc. (NVAX) - free report >>